Myriad Genetics Inc (MYGN) shareholders
Close on Nov 17, 2026Market cap $529.90MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock Portfolio Management LLC | 8,219,061 | 8.60% | 13G (passive) amendment | Sep 30, 2026 |
| BlackRock, Inc. | 7,976,163 | 8.50% | 13G (passive) amendment | Mar 31, 2026 |
| Israel A. Englander Joint filing with Millennium Management LLC (7.20%), Millennium Group Management LLC (7.20%) and 1 more | 6,700,158 | 7.20% | 13G (passive) amendment | Dec 31, 2025 |
| Wellington Management Company LLP Joint filing with Wellington Management Group LLP (6.60%), Wellington Group Holdings LLP (6.60%) and 1 more | 6,004,598 | 6.00% | 13G (passive) amendment | Dec 31, 2024 |
| Vestal Point Capital, LP Joint filing with Ryan Wilder (6.10%) | 5,735,000 | 6.10% | 13G (passive) | Jun 30, 2026 |
| State Street Corporation | 4,985,060 | 5.30% | 13G (passive) | Jun 30, 2026 |
| Glenview Capital Management, LLC Joint filing with Robbins Larry (5.30%) | 4,941,058 | 5.30% | 13G (passive) | Jan 6, 2026 |
| Millennium Management LLC Joint filing with Millennium Group Management LLC (5.30%), Israel A. Englander (5.30%) | 4,924,714 | 5.30% | 13G (passive) amendment | Jun 30, 2025 |
| Wellington Group Holdings LLP Joint filing with Wellington Management Group LLP (5.00%), Wellington Investment Advisors Holdings LLP (5.00%) | 4,592,264 | 5.00% | 13G (passive) amendment | Mar 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of MYGN | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 10,890,440 | 11.39% | $62.18M | +2,000,796 | 0.00% |
| Millennium Management LLC | 6,620,372 | 6.92% | $37.80M | −48,445 | 0.01% |
| Vestal Point Capital, LP | 5,735,000 | 6.00% | $32.75M | +4,087,000 | 0.77% |
| State Street Corp | 4,985,060 | 5.21% | $28.46M | +561,033 | 0.00% |
| D. E. Shaw & Co., Inc. | 4,582,083 | 4.79% | $26.16M | +82,359 | 0.01% |
| Vanguard Capital Management LLC | 4,081,376 | 4.27% | $23.30M | +156,851 | 0.00% |
| Acadian Asset Management LLC | 3,126,973 | 3.27% | $17.84M | +818,384 | 0.02% |
| Vanguard Portfolio Management LLC | 3,079,670 | 3.22% | $17.58M | +497,439 | 0.00% |
| Aqr Capital Management LLC | 2,766,689 | 2.89% | $15.80M | +854,393 | 0.01% |
| Morgan Stanley | 2,481,104 | 2.59% | $14.17M | −687,638 | 0.00% |
| Geode Capital Management, LLC | 2,416,197 | 2.53% | $13.80M | +96,818 | 0.00% |
| Assenagon Asset Management S.A. | 2,062,928 | 2.16% | $11.78M | +615,967 | 0.01% |
| Goldman Sachs Group Inc | 2,056,843 | 2.15% | $11.74M | −309,249 | 0.00% |
| Jacobs Levy Equity Management, Inc | 1,891,527 | 1.98% | $10.80M | −196,965 | 0.04% |
| Charles Schwab Investment Management Inc | 1,740,794 | 1.82% | $9.94M | −60,684 | 0.00% |
| Qube Research & Technologies Ltd | 1,665,835 | 1.74% | $9.51M | −24,626 | 0.01% |
| Federated Hermes, Inc. | 1,570,314 | 1.64% | $8.97M | −405,852 | 0.01% |
| Two Sigma Investments, LP | 1,557,727 | 1.63% | $8.89M | +273,677 | 0.01% |
| Nuveen, LLC | 1,545,549 | 1.62% | $8.83M | +626,586 | 0.00% |
| Mackenzie Financial Corp | 1,535,702 | 1.61% | $8.77M | New | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 197 | 90M | 94.1% | 44 / 76 | 58 / 45 | 20M | 18M |
| Q1 2026 | 203 | 88M | 92.1% | 33 / 75 | 68 / 48 | 21M | 16M |
| Q4 2025 | 221 | 92M | 96.4% | 31 / 85 | 75 / 26 | 10M | 6M |
| Q3 2025 | 221 | 89M | 93.1% | 41 / 77 | 69 / 37 | 13M | 13M |
| Q2 2025 | 221 | 90M | 94.6% | 43 / 91 | 53 / 49 | 23M | 27M |
| Q1 2025 | 228 | 94M | 98.3% | 38 / 79 | 78 / 29 | 10M | 8M |
| Q4 2024 | 221 | 92M | 96.7% | 33 / 91 | 74 / 57 | 11M | 10M |
| Q3 2024 | 246 | 91M | 95.4% | 48 / 85 | 72 / 23 | 23M | 10M |
| Q2 2024 | 223 | 93M | 97.0% | 54 / 72 | 64 / 15 | 7M | 11M |
| Q1 2024 | 186 | 97M | 100.0% | 21 / 73 | 62 / 29 | 9M | 3M |
| Q4 2023 | 194 | 91M | 95.0% | 28 / 78 | 61 / 19 | 11M | 2M |
| Q3 2023 | 186 | 83M | 86.5% | 16 / 69 | 72 / 17 | 6M | 4M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
208 funds held MYGN in Q2 2026, 57% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of MYGN | Value | % of fund | As of |
|---|---|---|---|---|---|
| State Street(R) SPDR(R) S&P(R) Biotech ETF | 3,015,479 | 3.15% | $17.22M | 0.16% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 2,881,677 | 3.01% | $16.45M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 2,415,960 | 2.53% | $13.80M | 0.02% | Jun 30, 2026 |
| Nuveen Quant Small Cap Equity Fund | 1,230,530 | 1.29% | $3.52M | 0.09% | Jul 31, 2026 |
| Federated Hermes MDT Small Cap Core Fund | 1,116,258 | 1.17% | $3.19M | 0.14% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 1,109,086 | 1.16% | $6.33M | 0.01% | Jun 30, 2026 |
| Vanguard Strategic Equity Fund | 1,021,536 | 1.07% | $5.83M | 0.05% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 1,009,496 | 1.06% | $2.89M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 859,842 | 0.90% | $4.91M | 0.03% | Jun 30, 2026 |
| Vanguard Strategic Small-Cap Equity Fund | 682,873 | 0.71% | $3.90M | 0.12% | Jun 30, 2026 |
| Fidelity Enhanced Small Cap Core ETF | 668,525 | 0.70% | $3.82M | 0.07% | Jun 30, 2026 |
| iShares Biotechnology ETF | 623,865 | 0.65% | $3.56M | 0.04% | Jun 30, 2026 |
| Schwab Fundamental U.S. Small Company ETF | 492,881 | 0.52% | $1.96M | 0.02% | May 31, 2026 |
| Vanguard Russell 2000 Index Fund | 471,590 | 0.49% | $1.87M | 0.01% | May 31, 2026 |
| Schwab U.S. Small-Cap ETF | 443,693 | 0.46% | $1.76M | 0.01% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Samraat S. Raha | President and CEO, Director | 1,068,083 | 1.12% | Jun 12, 2026 |
| Paul J. Diaz | President and CEO, Director | 891,844 | 0.93% | Apr 30, 2025 |
| Vishal Sikri | EVP, Commercial | 93,493 | 0.10% | Nov 9, 2026 |
| Jennifer Lynne Fox | Chief Legal & Corp Strategy | 345,334 | 0.36% | Nov 9, 2026 |
| Raj Jampa | Chief Technology Officer | 251,889 | 0.26% | Nov 9, 2026 |
| Benjamin Richard Wheeler | Chief Financial Officer | 287,193 | 0.30% | Nov 9, 2026 |
| Mark Verratti | Chief Operating Officer | 629,646 | 0.66% | Nov 9, 2026 |
| Dale Muzzey | Chief Scientific Officer | 326,310 | 0.34% | Nov 9, 2026 |
| Shereen Solaiman | Chief People Officer | 267,801 | 0.28% | Nov 9, 2026 |
| Brian J. Donnelly | Chief Commercial Officer | 573,363 | 0.60% | Sep 18, 2026 |
| Kevin Richard Haas | Chief Technology Officer | 188,404 | 0.20% | Mar 16, 2026 |
| Margaret Ancona | EVP, Strategy & Transformation | 127,726 | 0.13% | Nov 4, 2025 |
| Natalie Munk | Chief Accounting Officer | 45,167 | 0.05% | Oct 24, 2025 |
| Scott J. Leffler | Chief Financial Officer | 218,393 | 0.23% | Aug 18, 2025 |
| Daniel Skovronsky | Director | 195,507 | 0.20% | Jun 23, 2026 |
| Rashmi Kumar | Director | 171,889 | 0.18% | Jun 9, 2026 |
| Mark Steven Davis | Director | 106,665 | 0.11% | Jun 5, 2026 |
| S. Louise Phanstiel | Director | 374,771 | 0.39% | Jun 5, 2026 |
| Paul Bisaro | Director | 157,142 | 0.16% | Jun 5, 2026 |
| Heinrich Dreismann | Director | 231,145 | 0.24% | Jun 5, 2026 |
| Colleen F. Reitan | Director | 152,030 | 0.16% | Jun 5, 2026 |
| Lee Nisley Newcomer | Director | 191,842 | 0.20% | Jun 5, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Jennifer Lynne Fox Chief Legal & Corp Strategy | Nov 1, 2026 | Award | +39,370 | – | – | 345,334 |
| Benjamin Richard Wheeler Chief Financial Officer | Sep 21, 2026 | Tax withholding | −2,555 | $4.01 | $10.25K | 287,193 |
| Vishal Sikri EVP, Commercial | Sep 16, 2026 | Award | +257,731 | – | – | 351,224 |
| Jennifer Lynne Fox Chief Legal Officer | Sep 3, 2026 | Tax withholding | −4,398 | $3.23 | $14.21K | 305,964 |
| Benjamin Richard Wheeler Chief Financial Officer | Aug 16, 2026 | Tax withholding | −8,761 | $3.03 | $26.55K | 289,748 |
| Samraat S. Raha President and CEO, Director | Jun 11, 2026 | Award | +3,542 | $3.94 | $13.96K | 1,068,083 |
| Brian J. Donnelly Chief Commerical Officer | Jun 11, 2026 | Award | +5,000 | $3.94 | $19.70K | 573,363 |
| Rashmi Kumar Director | Jun 8, 2026 | Sale(10b5-1 plan) | −15,000 | $4.46 | $66.90K | 171,889 |
| Rashmi Kumar Director | Jun 4, 2026 | Award | +59,701 | – | – | 186,889 |
| Paul Bisaro Director | Jun 4, 2026 | Award | +59,701 | – | – | 157,142 |
| Colleen F. Reitan Director | Jun 4, 2026 | Award | +59,701 | – | – | 152,030 |
| Daniel Skovronsky Director | Jun 4, 2026 | Award | +59,701 | – | – | 195,507 |
| Lee Nisley Newcomer Director | Jun 4, 2026 | Award | +59,701 | – | – | 191,842 |
| Heinrich Dreismann Director | Jun 4, 2026 | Award | +59,701 | – | – | 231,145 |
| S. Louise Phanstiel Director | Jun 4, 2026 | Award | +59,701 | – | – | 341,652 |
| Mark Steven Davis Director | Jun 4, 2026 | Award | +59,701 | – | – | 106,665 |
| Raj Jampa Chief Technology Officer | Jun 1, 2026 | Award | +251,889 | – | – | 251,889 |
| Paul Bisaro Director | May 14, 2026 | Buy | +7,500 | $3.69 | $27.68K | 97,441 |
| Brian J. Donnelly Chief Commerical Officer | May 1, 2026 | Tax withholding | −55,975 | $4.80 | $268.68K | 568,363 |
| Mark Verratti Chief Operating Officer | Apr 14, 2026 | Tax withholding | −1,069 | $4.91 | $5.25K | 629,646 |
| Dale Muzzey Chief Scientific Officer | Apr 14, 2026 | Tax withholding | −946 | $4.91 | $4.64K | 326,310 |
| Dale Muzzey Chief Scientific Officer | Mar 22, 2026 | Tax withholding | −2,019 | $4.58 | $9.25K | 327,256 |
| Benjamin Richard Wheeler Chief Financial Officer | Mar 22, 2026 | Tax withholding | −549 | $4.58 | $2.51K | 298,509 |
| Mark Verratti Chief Operating Officer | Mar 22, 2026 | Tax withholding | −2,055 | $4.58 | $9.41K | 630,715 |
| Dale Muzzey Chief Scientific Officer | Mar 15, 2026 | Tax withholding | −11,949 | $4.66 | $55.68K | 329,275 |
| Dale Muzzey Chief Scientific Officer | Mar 15, 2026 | Tax withholding | −4,783 | $4.66 | $22.29K | 341,224 |
| Mark Verratti Chief Operating Officer | Mar 15, 2026 | Tax withholding | −5,611 | $4.66 | $26.15K | 641,866 |
| Mark Verratti Chief Operating Officer | Mar 15, 2026 | Tax withholding | −9,096 | $4.66 | $42.39K | 632,770 |
| Benjamin Richard Wheeler Chief Financial Officer | Mar 15, 2026 | Tax withholding | −877 | $4.66 | $4.09K | 301,250 |
| Benjamin Richard Wheeler Chief Financial Officer | Mar 15, 2026 | Tax withholding | −2,192 | $4.66 | $10.21K | 299,058 |
| Kevin Richard Haas Chief Technology Officer | Mar 15, 2026 | Tax withholding | −3,355 | $4.66 | $15.63K | 188,404 |
| Kevin Richard Haas Chief Technology Officer | Mar 15, 2026 | Tax withholding | −8,382 | $4.66 | $39.06K | 180,022 |
| Dale Muzzey Chief Scientific Officer | Mar 14, 2026 | Tax withholding | −8,288 | $4.66 | $38.62K | 346,007 |
| Shereen Solaiman Chief People Officer | Mar 14, 2026 | Tax withholding | −5,784 | $4.66 | $26.95K | 267,801 |
| Mark Verratti Chief Operating Officer | Mar 14, 2026 | Tax withholding | −5,418 | $4.66 | $25.25K | 647,477 |
| Benjamin Richard Wheeler Chief Financial Officer | Mar 14, 2026 | Tax withholding | −1,097 | $4.66 | $5.11K | 302,127 |
| Samraat S. Raha President and CEO, Director | Mar 14, 2026 | Tax withholding | −10,816 | $4.66 | $50.40K | 1,064,541 |
| Kevin Richard Haas Chief Technology Officer | Mar 14, 2026 | Tax withholding | −4,161 | $4.66 | $19.39K | 191,759 |
| Dale Muzzey Chief Scientific Officer | Mar 13, 2026 | Tax withholding | −12,779 | $4.66 | $59.55K | 354,295 |
| Shereen Solaiman Chief People Officer | Mar 13, 2026 | Tax withholding | −8,899 | $4.66 | $41.47K | 273,585 |
| Mark Verratti Chief Operating Officer | Mar 13, 2026 | Tax withholding | −9,164 | $4.66 | $42.70K | 652,895 |
| Benjamin Richard Wheeler Chief Financial Officer | Mar 13, 2026 | Tax withholding | −586 | $4.66 | $2.73K | 303,224 |
| Jennifer Lynne Fox Chief Legal Officer | Mar 13, 2026 | Tax withholding | −5,995 | $4.66 | $27.94K | 310,362 |
| Samraat S. Raha President and CEO, Director | Mar 13, 2026 | Tax withholding | −36,304 | $4.66 | $169.18K | 1,075,357 |
| Kevin Richard Haas Chief Technology Officer | Mar 13, 2026 | Tax withholding | −6,412 | $4.66 | $29.88K | 195,920 |
| Dale Muzzey Chief Scientific Officer | Mar 12, 2026 | Award | +173,196 | – | – | 367,074 |
| Shereen Solaiman Chief People Officer | Mar 12, 2026 | Award | +173,196 | – | – | 282,484 |
| Mark Verratti Chief Operating Officer | Mar 12, 2026 | Award | +247,423 | – | – | 662,059 |
| Benjamin Richard Wheeler Chief Financial Officer | Mar 12, 2026 | Award | +206,186 | – | – | 303,810 |
| Brian J. Donnelly Chief Commerical Officer | Mar 12, 2026 | Award | +226,804 | – | – | 624,338 |
| Jennifer Lynne Fox Chief Legal Officer | Mar 12, 2026 | Award | +195,876 | – | – | 316,357 |
| Samraat S. Raha President and CEO, Director | Mar 12, 2026 | Award | +618,557 | – | – | 1,111,661 |
| Samraat S. Raha President and CEO, Director | Mar 9, 2026 | Buy | +40,000 | $5.00 | $200.00K | 493,104 |
| Shereen Solaiman Chief People Officer | Mar 1, 2026 | Tax withholding | −1,675 | $4.61 | $7.72K | 109,288 |
| S. Louise Phanstiel Director | Feb 27, 2026 | Buy | +48,000 | $4.66 | $223.68K | 281,951 |
| S. Louise Phanstiel Director | Feb 26, 2026 | Buy | +50,407 | $4.80 | $241.95K | 233,951 |
| S. Louise Phanstiel Director | Feb 25, 2026 | Buy | +6,100 | $4.74 | $28.91K | 183,544 |
| Dale Muzzey Chief Scientific Officer | Feb 2, 2026 | Award | +23,697 | – | – | 193,878 |
| Kevin Richard Haas Chief Technology Officer | Feb 2, 2026 | Award | +23,697 | – | – | 202,332 |
| Benjamin Richard Wheeler Chief Financial Officer | Feb 2, 2026 | Award | +4,994 | – | – | 97,624 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Myriad Genetics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 10,635 shares on Sep 22, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Rashmi Kumar Director | Jun 8, 2026 | 15,000 | $68.85K | Jun 8, 2026 | Restricted Stock Vesting |
| Paul J. Diaz Officer, Director | Oct 11, 2024 | 15,000 | $343.95K | Oct 11, 2024 | Restricted Stock Vesting |
| Margaret Ancona Officer | Sep 16, 2024 | 11,538 | $321.02K | Aug 21, 2024 | Stock Bonus |
| Dale Muzzey Officer | Sep 11, 2024 | 2,100 | $54.96K | Sep 11, 2024 | Restricted Stock Vesting |
| Paul J. Diaz Officer, Director | Sep 11, 2024 | 15,000 | $400.80K | Sep 11, 2024 | Restricted Stock Vesting |
| Heinrich Dreismann Director | Sep 9, 2024 | 10,000 | $270.00K | Sep 10, 2024 | stock bonus |
| Colleen F. Reitan Director | Sep 3, 2024 | 46,012 | $1.30M | Sep 3, 2024 | Restricted Stock Vesting |
| Rashmi Kumar Director | Aug 19, 2024 | 7,500 | $210.08K | Aug 19, 2024 | Restricted Stock Vesting |
| Daniel K. Spiegelman Director | Jun 4, 2024 | 3,788 | $83.53K | Jun 4, 2024 | Restricted Stock Vesting |
| Daniel K. Spiegelman Director | Jun 3, 2024 | 3,788 | $83.49K | Jun 3, 2024 | Restricted Stock Vesting |
| Paul J. Diaz Officer, Director | May 15, 2024 | 75,000 | $1.88M | May 15, 2024 | Restricted Stock Vesting |
| Paul J. Diaz Officer, Director | May 14, 2024 | 95,000 | $2.39M | May 14, 2024 | Restricted Stock Vesting |
| Paul J. Diaz Officer, Director | May 13, 2024 | 57,844 | $1.45M | May 13, 2024 | Restricted Stock Vesting |
| Lee Nisley Newcomer Director | May 13, 2024 | 6,200 | $156.86K | May 13, 2024 | Restricted Stock Vesting |
| Richard Bryan Riggsbee Affiliate | Apr 10, 2024 | 75,000 | $1.50M | Apr 10, 2024 | Vested RSUs granted 3/15/2023 |
See a number that looks wrong?